COVID-19 in ocrelizumab-treated people with multiple sclerosis.
Hughes R, Whitley L, Fitovski K, Schneble HM, Muros E, Sauter A, Craveiro L, Dillon P, Bonati U, Jessop N, Pedotti R, Koendgen H.
Hughes R, et al. Among authors: dillon p.
Mult Scler Relat Disord. 2021 Apr;49:102725. doi: 10.1016/j.msard.2020.102725. Epub 2020 Dec 30.
Mult Scler Relat Disord. 2021.
PMID: 33482590
Free PMC article.